Sunscreen

Our Position

While a small select group have raised concerns about certain sunscreen ingredients, banning or restricting common UV filters could negatively impact public health. Sunscreen use is recommended by the Centers for Disease Control and Prevention, World Health Organization, American Academy of Dermatology, and other experts as part of a comprehensive sun protection strategy. Limiting sunscreen options could discourage daily use, leading to increased sunburn, photoaging, and skin cancer risk. Currently, no studies directly link FDA-approved sunscreen active ingredients like avobenzone, oxybenzone, and octinoxate to human health harms when used properly.

Read More

Browse Sunscreen Content

Biking into the Sunset

Submission

Comments to FDA: TFM Sunscreen Drug Products for OTC Human Use

Because of their well-established role in protecting public health, the significant benefits provided by sunscreens need to be appropriately weighed against any potential risks. We support FDA’s commitment to ensuring that sunscreens are safe and effective for their intended use.

Jun 26, 2019

woman in hat running at sunset

Submission

Comments to FDA: Sunscreen Drug Products for OTC Human Use

The Personal Care Products Council and CHPA write in response to the proposed rule from FDA regarding sunscreen drug products for OTC human use. We write to request that the following sunscreen active ingredients be deferred from inclusion in the final rule.

Jun 26, 2019

orange bottle of sunscreen

Submission

Comments to FDA: TFM for Sunscreen Drug Products

We support FDA's commitment to ensuring that sunscreens are safe and effective for their intended use. We are confident that currently marketed sunscreens are both safe and effective.

Jun 26, 2019

woman in hat running at sunset

Press Releases and Statements

Statement by CHPA in Response to FDA’s Proposed Sunscreen Rule

CHPA responds to FDA’s Proposed Rule on Sunscreen Drug Products for Over-the-Counter Human Use

Feb 21, 2019

woman in hat running at sunset

Press Releases and Statements

Statement from the Consumer Healthcare Products Association Regarding Hawaii Sunscreen

Overwhelming scientific evidence shows that excess sun exposure without sunscreen increases the risk of developing skin cancer. Banning key ingredients in effective sunscreens will unnecessarily reduce the selection of safe and effective sunscreen products available.

May 3, 2018

Colleagues Examining Data on a computer

Submission

Comments to FDA: OTC Sunscreens Safety and Effectiveness Data

Comments regarding guidance for industry pertaining to sunscreen ingredients requesting inclusion into the OTC sunscreen monograph.

Feb 22, 2016

Biking into the Sunset

Submission

Comments to FDA: Sunscreen Innovation Act

Enclosed herein are comments on "Guidance for Industry; Sunscreen Innovation Act: Section 586C(c) Advisory Committee Process."

Jan 19, 2016

Orange CHPA logo on dark blue background

Submission

Comments to FDA: SIA, Withdrawal of a 586A Request or Pending Request

Enclosed herein are comments on "Guidance for Industry; Sunscreen Innovation Act: Withdrawal of a 586A Request or Pending Request", published as Draft Guidance.

Jan 19, 2016

Colleagues Examining Data on a computer

Submission

Comments to FDA: Sunscreen Drug Products - Content and Format of Data Submissions

Enclosed herein are comments on "Guidance for Industry; Nonprescription Sunscreen Drug Products - Content and Format of Data Submissions to Support a GRASE determination Under the Sunscreen Innovation Act."

Jan 19, 2016

orange bottle of sunscreen

Submission

Comments to FDA: Sunscreen Feedback Letters

We ask that in its review of the Proposed Orders, FDA take our framework into consideration when making its GRASE determinations.

Feb 23, 2015

Filter Results